News
2 Jul 2021
Kymos Acquires Germany’s Prolytic
Dorothee Krone, managing director of Prolytic, and Joan Puig de Dou, CEO of Kymos, sign the merger contract for Kymos and Prolytic to become Kymos Group. © Kymos Group
Kymos, a Contract Research Organisation (CRO) and member of CataloniaBio & HealthTech, has bought German company Prolytic GmbH in order to strengthen its activity in the biologics and advanced therapies market. The company previously acquired Italian firm Pharmaprogress in 2016.
Germany: Kymos creates pan-European CRO
Mentioned Companies
Kymos Group, S.L
